Drug derived from malaria parasite could be utilized in bladder cancer
Researchers at the University of British Columbia (Vancouver, BC, Canada) have demonstrated that a drug created from a malaria protein, stopped tumour growth of chemotherapy-resistant bladder cancer, offering hope for cancer patients not responding to standard treatments.
Please sign in or register for FREE to view this content
Sign in to MedChemNet
Register to MedChemNet – the medicinal chemistry network
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.